Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $261,673 - $285,491
3,539 New
3,539 $265,000
Q2 2022

Aug 11, 2022

BUY
$57.72 - $65.01 $400,519 - $451,104
6,939 New
6,939 $429,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ground Swell Capital, LLC Portfolio

Follow Ground Swell Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ground Swell Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ground Swell Capital, LLC with notifications on news.